Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

430 public trials 126 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

A Study of Personalized Neoantigen Cancer Vaccines

NCT03794128

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
Locations
  • University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York, United States
  • The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Completed

The Cxbladder Monitoring Study

NCT02700659

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Urology Center of Grove Hill, One Lake Street New Britain, Connecticut, United States
  • Florida Urology Associates Orlando, Florida, United States
  • Idaho Urologic Institute Meridian, Idaho, United States
View Trial Details
Completed

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

NCT00722553

Conditions
Bladder Cancer, Bladder Neoplasm, Carcinoma, +20 more
Locations
  • The University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Peachtree Hematology/Oncology Consultants Atlanta, Georgia, United States
  • University of Rochester Cancer Center Rochester, New York, United States
  • University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States
View all 19 locations
View Trial Details
Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

NCT01478685

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 13 locations
View Trial Details
Completed

Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer

NCT02351739

Conditions
Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Durham, North Carolina, United States
  • James Cancer Hospital Columbus, Ohio, United States
View Trial Details

Related conditions